# 18F-AV-1451 Autopsy Study

> **NCT02516046** · PHASE3 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 156 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Flortaucipir F18
- **PROCEDURE:** PET Scan

## Key facts

- **NCT ID:** NCT02516046
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-06-13
- **Final completion:** 2018-07-15
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2020-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516046, "18F-AV-1451 Autopsy Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02516046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*